Literature DB >> 15801720

Chitosan-based particles as controlled drug delivery systems.

M Prabaharan1, J F Mano.   

Abstract

Chitosan, a natural-based polymer obtained by alkaline deacetylation of chitin, is nontoxic, biocompatible, and biodegradable. These properties make chitosan a good candidate for conventional and novel drug delivery systems. This article reviews the approaches aimed to associate bioactive molecules to chitosan in the form of colloidal structures and analyzes the evidence of their efficacy in improving the transport of the associated molecule through mucosae and epithelia. Chitosan forms colloidal particles and entraps bioactive molecules through a number of mechanisms, including chemical crosslinking, ionic crosslinking, and ionic complexation. A possible alternative of chitosan by the chemical modification also has been useful for the association of bioactive molecules to polymer and controlling the drug release profile. Because of the high affinity of chitosan for cell membranes, it has been used as a coating agent for liposome formulations. This review also examines the advances in the application of chitosan and its derivatives to nonviral gene delivery and gives an overview of transfection studies that use chitosan as a transfection agent. From the studies reviewed, we concluded that chitosan and its derivatives are promising materials for controlled drug and nonviral gene delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15801720     DOI: 10.1080/10717540590889781

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  53 in total

1.  Electroformation of giant vesicles from an inverse phase precursor.

Authors:  Omar Mertins; Nádya P da Silveira; Adriana R Pohlmann; André P Schröder; Carlos M Marques
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

2.  Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.

Authors:  Chunqiang Guo; Richard A Gemeinhart
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

3.  Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.

Authors:  Meng-Hsuan Hsiao; Qingxin Mu; Zachary R Stephen; Chen Fang; Miqin Zhang
Journal:  ACS Macro Lett       Date:  2015-03-23       Impact factor: 6.903

4.  Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.

Authors:  Tianzhi Yang; Divine Nyiawung; Alexandra Silber; Jiukuan Hao; Leanne Lai; Shuhua Bai
Journal:  AAPS PharmSciTech       Date:  2012-09-28       Impact factor: 3.246

Review 5.  Nanoparticles and nanofibers for topical drug delivery.

Authors:  Ritu Goyal; Lauren K Macri; Hilton M Kaplan; Joachim Kohn
Journal:  J Control Release       Date:  2015-10-28       Impact factor: 9.776

6.  In vitro comparison of three rifampicin loading methods in a reinforced porous β-tricalcium phosphate scaffold.

Authors:  Junjie Yuan; Baoxin Wang; Chen Han; Xiao Lu; Wei Sun; Dezhi Wang; Jianxi Lu; Jie Zhao; Chao Zhang; Youzhuan Xie
Journal:  J Mater Sci Mater Med       Date:  2015-03-28       Impact factor: 3.896

7.  Processing and characterization of chitosan microspheres to be used as templates for layer-by-layer assembly.

Authors:  Jessica M R Grech; João F Mano; Rui L Reis
Journal:  J Mater Sci Mater Med       Date:  2010-04-03       Impact factor: 3.896

8.  Alginate/chitosan nanoparticles are effective for oral insulin delivery.

Authors:  B Sarmento; A Ribeiro; F Veiga; P Sampaio; R Neufeld; D Ferreira
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

9.  Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice.

Authors:  Dan-Ying Zhang; Xi-Zhong Shen; Ji-Yao Wang; Ling Dong; Yong-Li Zheng; Li-Li Wu
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

10.  Isolation, characterization and heterologous expression of a novel chitosanase from Janthinobacterium sp. strain 4239.

Authors:  Mads G Johnsen; Ole C Hansen; Peter Stougaard
Journal:  Microb Cell Fact       Date:  2010-01-22       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.